Pharmaceutical South Africa’s largest drugmaker Aspen Pharmacare closed up more than 5% at 14,750 rand yesterday, after it announced that one of its wholly-owned South African subsidiaries, Aspen SA Operations, has concluded a 10-year agreement with Serum Institute of India (SII) for Aspen SA Operations to manufacture, market and distribute four Aspen-branded routine vaccines in Africa, excluding certain markets due to the Serum Institute having grated prior rights to third parties. 1 September 2022